F Marc LaForce

Summary

Affiliation: Program for Appropriate Technology in Health
Country: USA

Publications

  1. doi request reprint Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine
    F Marc LaForce
    Program for Appropriate Technology in Health, in Washington, DC, USA
    Health Aff (Millwood) 30:1049-57. 2011
  2. ncbi request reprint The Meningitis Vaccine Project
    F Marc LaForce
    The Meningitis Vaccine Project, PATH, 13 Chemin du Levant, 01210 Ferney Voltaire, France
    Vaccine 25:A97-100. 2007

Detail Information

Publications2

  1. doi request reprint Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine
    F Marc LaForce
    Program for Appropriate Technology in Health, in Washington, DC, USA
    Health Aff (Millwood) 30:1049-57. 2011
    ..The vaccine's low cost--less than fifty cents per dose--makes it possible for the affected countries themselves to purchase vaccines for future birth cohorts...
  2. ncbi request reprint The Meningitis Vaccine Project
    F Marc LaForce
    The Meningitis Vaccine Project, PATH, 13 Chemin du Levant, 01210 Ferney Voltaire, France
    Vaccine 25:A97-100. 2007
    ..The MVP model is a clear example of the usefulness of a "push mechanism" to finance the development of a needed vaccine for the developing world...